Total Payments
$2,963
2023 Payments
$223.71
Companies
20
Transactions
178
Medicare Patients
2,717
Medicare Billing
$512,650
Payment Breakdown by Category
Food & Beverage$2,932 (98.9%)
Education$31.70 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,932 | 173 | 98.9% |
| Education | $31.70 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $871.56 | 46 | $0 (2023) |
| GlaxoSmithKline, LLC. | $781.26 | 52 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $427.65 | 22 | $0 (2023) |
| Mylan Specialty L.P. | $107.69 | 8 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $104.50 | 9 | $0 (2020) |
| Amgen Inc. | $100.86 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $93.28 | 5 | $0 (2023) |
| Grifols USA, LLC | $81.02 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $66.80 | 3 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $63.79 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $223.71 | 10 | AstraZeneca Pharmaceuticals LP ($95.39) |
| 2022 | $337.81 | 16 | AstraZeneca Pharmaceuticals LP ($124.51) |
| 2021 | $51.48 | 3 | GlaxoSmithKline, LLC. ($32.11) |
| 2020 | $155.17 | 9 | AstraZeneca Pharmaceuticals LP ($52.62) |
| 2019 | $974.16 | 60 | GlaxoSmithKline, LLC. ($488.78) |
| 2018 | $703.60 | 43 | AstraZeneca Pharmaceuticals LP ($249.47) |
| 2017 | $517.42 | 37 | AstraZeneca Pharmaceuticals LP ($118.85) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Respiratory | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Respiratory | ||||||
| 04/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: PAH | ||||||
| 02/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Inflammation | ||||||
| 01/11/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Respiratory | ||||||
| 11/16/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Respiratory | ||||||
| 11/03/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Respiratory | ||||||
| 11/03/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Inflammation | ||||||
| 11/02/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Respiratory | ||||||
| 10/19/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Immunology | ||||||
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 10/06/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Inflammation | ||||||
| 10/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Respiratory | ||||||
| 08/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Inflammation | ||||||
| 08/10/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 656 | 970 | $321,393 | $110,813 |
| 2022 | 15 | 738 | 1,277 | $400,489 | $148,135 |
| 2021 | 14 | 645 | 1,096 | $324,564 | $122,951 |
| 2020 | 13 | 678 | 1,183 | $379,955 | $130,751 |
Total Patients
2,717
Total Services
4,526
Medicare Billing
$512,650
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 106 | 281 | $161,575 | $50,935 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 266 | $66,500 | $25,739 | 38.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 83 | 147 | $41,013 | $15,023 | 36.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 52 | $20,800 | $7,746 | 37.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $8,925 | $3,509 | 39.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 31 | 31 | $7,750 | $3,073 | 39.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 25 | 32 | $8,000 | $2,917 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,400 | $843.88 | 35.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 41 | 41 | $1,025 | $380.04 | 37.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 40 | 41 | $2,255 | $330.22 | 14.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 45 | 46 | $1,150 | $316.26 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 505 | $126,250 | $53,001 | 42.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 92 | 277 | $159,275 | $51,755 | 32.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 131 | $36,549 | $11,241 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 42 | 42 | $17,850 | $8,238 | 46.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 50 | 72 | $18,000 | $6,816 | 37.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 38 | $15,200 | $6,449 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 22 | $6,600 | $3,311 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,650 | $2,761 | 41.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 21 | 21 | $5,250 | $1,943 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 19 | $3,800 | $1,247 | 32.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 36 | 36 | $900.00 | $367.04 | 40.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 39 | 39 | $975.00 | $287.61 | 29.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 34 | 34 | $1,870 | $278.58 | 14.9% |
| 94070 | Test to measure lung airway sensitivity | Facility | 2022 | 11 | 11 | $715.00 | $271.36 | 38.0% |
About Dr. Kimberly Robinson, MD
Dr. Kimberly Robinson, MD is a Pulmonary Disease healthcare provider based in Marlborough, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801990056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kimberly Robinson, MD has received a total of $2,963 in payments from pharmaceutical and medical device companies, with $223.71 received in 2023. These payments were reported across 178 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,932).
As a Medicare-enrolled provider, Robinson has provided services to 2,717 Medicare beneficiaries, totaling 4,526 services with total Medicare billing of $512,650. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Marlborough, MA
- Active Since 09/09/2006
- Last Updated 05/19/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1801990056
Products in Payments
- FASENRA (Drug) $348.01
- ANORO (Drug) $328.28
- OFEV (Drug) $321.72
- TRELEGY ELLIPTA (Drug) $291.40
- TEZSPIRE (Biological) $218.01
- SYMBICORT (Drug) $187.20
- NUCALA (Biological) $127.88
- FASENRA (Biological) $102.75
- XOLAIR (Biological) $76.62
- BEVESPI AEROSPHERE (Drug) $71.56
- DUPIXENT (Biological) $59.80
- CINQAIR (Drug) $51.62
- Perforomist (Drug) $50.47
- Prolastin-C (Biological) $48.52
- BROVANA (Drug) $45.70
- Dymista (Drug) $40.51
- STIOLTO RESPIMAT (Drug) $40.04
- Prolastin-C Liquid (Biological) $32.50
- SMARTVEST (Device) $31.40
- LONHALA MAGNAIR (Drug) $31.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.